E. Ohman J:Or Asset Management Ab Cytokinetics Inc Transaction History
E. Ohman J:Or Asset Management Ab
- $3.76 Trillion
- Q1 2025
A detailed history of E. Ohman J:Or Asset Management Ab transactions in Cytokinetics Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 329,231 shares of CYTK stock, worth $13.1 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
329,231Holding current value
$13.1 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
400Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$584 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$474 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$428 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$246 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$113 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...